Porphyria cutanea tarda the commonest form of porphyria; Its medical control a team task;Porphyria cutanea tarda vanligaste porfyriformen: Den medicinska kontrollen ett lagarbete

Lakartidningen

Volumn , Issue 28-29, 1998, Pages 3195-3199

  Harper, Pauline ^a   Thunell, Stig ^a   Hultcrantz, Rolf ^a   Ros, Anne Marie ^a   Wennersten, Göran ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Hudmottagningen vid B   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

UROPORPHYRINOGEN DECARBOXYLASE;

CHEMISTRY; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; LIVER DISEASE; METABOLISM; PATIENT CARE; PATIENT CARE PLANNING; PORPHYRIA CUTANEA TARDA; REVIEW; SKIN DISEASE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER DISEASES; PATIENT CARE PLANNING; PATIENT CARE TEAM; PORPHYRIA CUTANEA TARDA; SKIN DISEASES; UROPORPHYRINOGEN DECARBOXYLASE;

EID: 0032496780     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ayala F, Santoianni P. Drug-induced cutaneous porphyria. Clin Dermatol 1993; 11: 535-9.
2. Elder GH, Roberts AG. Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 1995; 27: 207-14.
3. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB. Iron liver diseases other than hemochromatosis. Semin Liver Dis 1996; 16: 65-82.
4. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282 Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
5. Blauvelt A. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 1996; 132: 1503-4.
6. Nomura N, Zolla-Pazner S, Simberkoff M, Kim M, Sassa S, Lim HW. Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection. Arch Dermatol 1996; 132: 906-10.
7. O'Connor WJ, Murphy GM, Darby C, Fogarty J, Mulcahy F, O'Moore R et al. Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 1996; 132: 1443-7.
8. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. Am J Med 1979; 67: 277-86.
9. Lamon JM, Frykholm BC. Pregnancy and porphyria cutanea tarda. Johns Hopkins Medical Journal 1979; 145: 235-7.
10. Rank JM, Straka JG, Bloomer JR. Liver in disorders of porphyrin metabolism: review article. J Gastroenterol Hepatol 1990; 5: 573-85.
11. Sierseme PD, Tenkate FJW, Mulder PGH, Wilson HPH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver 1992; 12: 56-61.
12. Poh-Fitzpatrick MB. Is porphyria cutanea tarda a paraneoplastic disorder? Clin Dermatol 1993; 11: 119-24.
13. Roux M, Grange C, Durand DV, Levrat R. Porphyrie cutanée tardive et infection par les virus de l'hepatite B et C. Presse Med 1996; 25: 1589-91.
14. Elder GH. The cutaneous porphyrias. Semin Dermatol 1990; 9: 63-9.
15. Seubert S, Seubert A, Stella AM, Guzman H, Batlle A. Ergebnisse bei der Behandlung der Porphyria cutanea tarda mit Aderlass und Resochin. Zeitschrift für Hautkrankheiten 1990; 65: 223-5.
16. Rocchi E, Stella AM, Casanelli M, Borghi A, Nardella N, Weium Y et al. Liposoluble vitamins and naturally occurring carotenoids in porphyria cutanea tarda. Eur J Clin Invest 1995; 25: 510-4.
17. Horie Y, Tanaka K, Okano J, Ohgi N, Kawasaki H, Yamamoto S et al. Cimetidine in the treatment of porphyria cutanea tarda. Intern Med 1996; 35: 717-9.
18. de Mola JRL, Muise KL, Duchon MA. Porphyria cutanea tarda and pregnancy. Obstetrical gynecological survey. Obstet Gynecol 1996; 51: 493-7.
19. Raika G. Pregnancy and porphyria cutanea tarda. Acta Derm Venereol 1984; 54: 444-5.
20. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 4th ed. Baltimore, MD: Williams & Wilkins, 1994.